ConductScience.org, home

Paper36036883

HDAC6: A unique HDAC family member as a cancer target.

Kaur S and 2 others. Cell Oncol (Dordr), 2022. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. HDAC6: A unique HDAC family member as a cancer target. Papers, record 36036883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36036883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HDAC6: A unique HDAC family member as a cancer target.
PubMed
Journal
Cell Oncol (Dordr)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
5.89
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaur SSumeet
2Rajoria PPrerna
3Chopra MMadhuhttps://orcid.org/0000-0003-3154-7335

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Animals
Mice
Histone Deacetylase 6
Histone Deacetylase Inhibitors
Proteasome Inhibitors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
19/06/2016(I)EU-VUniversity Grants CommissionPubMed
DBT/2021-22/CBR/1593Department of Biotechnology, Government of IndiaPubMed

Source PubMed

Download CSV of grants

References234

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135223194Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer.Oncoimmunology2022https://conductscience.org/library/papers/35223194PubMed
216192271HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.J Biol Chem2005https://conductscience.org/library/papers/16192271PubMed
326824318MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer.Oncotarget2016https://conductscience.org/library/papers/26824318PubMed
415937340Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.J Biol Chem2005https://conductscience.org/library/papers/15937340PubMed
518804549Acetylation of non-histone proteins modulates cellular signalling at multiple levels.Int J Biochem Cell Biol2009https://conductscience.org/library/papers/18804549PubMed
617785525HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates.Genes Dev2007https://conductscience.org/library/papers/17785525PubMed
723627282Development and therapeutic implications of selective histone deacetylase 6 inhibitors.J Med Chem2013https://conductscience.org/library/papers/23627282PubMed
829917295A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells.Mol Carcinog2018https://conductscience.org/library/papers/29917295PubMed
929278704HDAC6 interacts with PTPN1 to enhance melanoma cells progression.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/29278704PubMed
1030667160Combined comparative molecular field analysis, comparative molecular similarity indices analysis, molecular docking and molecular dynamics studies of histone deacetylase 6 inhibitors.Chem Biol Drug Des2019https://conductscience.org/library/papers/30667160PubMed
1120008322IIp45 inhibits cell migration through inhibition of HDAC6.J Biol Chem2010https://conductscience.org/library/papers/20008322PubMed
1233024443Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials.Front Genet2020https://conductscience.org/library/papers/33024443PubMed
1323950178PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma.Blood2013https://conductscience.org/library/papers/23950178PubMed
146863393Chlamydomonas alpha-tubulin is posttranslationally modified in the flagella during flagellar assembly.J Cell Biol1983https://conductscience.org/library/papers/6863393PubMed
1530867374Novel HDAC6 selective inhibitors with 4-aminopiperidine-1- carboxamide as the core structure enhanced growth inhibitory activity of bortezomib in MCF-7 cells.Biosci Trends2019https://conductscience.org/library/papers/30867374PubMed
1629880608In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma.Haematologica2018https://conductscience.org/library/papers/29880608PubMed
1722936009The role of HDAC6 in Alzheimer's disease.J Alzheimers Dis2013https://conductscience.org/library/papers/22936009PubMed
1812486003In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.EMBO J2002https://conductscience.org/library/papers/12486003PubMed
1923905680Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.J Med Chem2013https://conductscience.org/library/papers/23905680PubMed
2027400681GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer.Cancer Lett2016https://conductscience.org/library/papers/27400681PubMed

See all 234 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42661166
Exploration of novel hydroxamic acid-based candidates integrating chalcone scaffold cap as multitarget HDAC inhibitors: design, anti-prostatic cancer assessment, in silico docking and molecular dynamic simulation.
J Enzyme Inhib Med Chem2026https://conductscience.org/library/papers/42661166PubMed
42176187An integrated machine learning and chemical space network approach for the design of potent epigenetic HDAC6 inhibitors for targeting neurological disorders.Mol Divers2026https://conductscience.org/library/papers/42176187PubMed
42063468Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions.Mil Med Res2026https://conductscience.org/library/papers/42063468PubMed
41999432Aucubin inhibits epithelial-mesenchymal transition and angiogenesis in colorectal cancer via the HDAC6/PI3K/Akt signaling pathway.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41999432PubMed
41850897Investigation of Novel Antiproliferative Drugs Interaction with mPEG2k-PCLy Copolymers Using Molecular Dynamics Simulation Approach.J Chem Inf Model2026https://conductscience.org/library/papers/41850897PubMed
41501879HDAC6 orchestrates metastatic and immunosuppressive programs in small cell lung cancer through S100A2-TGF-β/SMAD and CSF1R signaling.Mol Cancer2026https://conductscience.org/library/papers/41501879PubMed
41498889Role of HDAC6 in carcinomas.Discov Oncol2026https://conductscience.org/library/papers/41498889PubMed
41335282Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications.Mol Biomed2025https://conductscience.org/library/papers/41335282PubMed
41082153Identifying the causal role and therapeutic potential of immune-related genes in bladder cancer: a Mendelian randomization study.Discov Oncol2025https://conductscience.org/library/papers/41082153PubMed
40641131Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review).Int J Mol Med2025https://conductscience.org/library/papers/40641131PubMed
40542929Assessment of test-retest reproducibility by [18F]Bavarostat for PET imaging of HDAC6.EJNMMI Res2025https://conductscience.org/library/papers/40542929PubMed
40532131Development and Characterization of the First Selective Class IIb Histone Deacetylase Degraders.J Med Chem2025https://conductscience.org/library/papers/40532131PubMed
40167251Histone Deacetylase 6 (HDAC6) in Ciliopathies: Emerging Insights and Therapeutic Implications.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40167251PubMed
39941046Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein-Protein Interactions.Int J Mol Sci2025https://conductscience.org/library/papers/39941046PubMed
39885716Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents.Future Med Chem2025https://conductscience.org/library/papers/39885716PubMed
39790566Histone deacetylase 6 inhibition prevents hypercholesterolemia-induced erectile dysfunction independent of changes in markers of autophagy.Sex Med2024https://conductscience.org/library/papers/39790566PubMed
39595195The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?Biomedicines2024https://conductscience.org/library/papers/39595195PubMed
39568023Adipose stem cell exosomes, stimulated by pro-inflammatory factors, enhance immune evasion in triple-negative breast cancer by modulating the HDAC6/STAT3/PD-L1 pathway through the transporter UCHL1.Cancer Cell Int2024https://conductscience.org/library/papers/39568023PubMed
39458584Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design.Pharmaceutics2024https://conductscience.org/library/papers/39458584PubMed
39433125Targeting chaperone modifications: Innovative approaches to cancer treatment.J Biol Chem2024https://conductscience.org/library/papers/39433125PubMed

See all 37 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HDAC610013PubTator's text mininghttps://conductscience.org/library/genes/10013

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36036883

GET https://conductscience.org/api/papers/v1/36036883/references?page=2